Cargando…

Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: Study of immunological memory and long-term toxicology

BACKGROUND: The human immunodeficiency virus type 1 (HIV-1) regulatory protein, Nef, is an attractive vaccine target because it is involved in viral pathogenesis, is expressed early in the viral life cycle and harbors many T and B cell epitopes. Several clinical trials include gene-based vaccines en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bråve, Andreas, Gudmundsdotter, Lindvi, Gasteiger, Georg, Hallermalm, Kristian, Kastenmuller, Wolfgang, Rollman, Erik, Boberg, Andreas, Engström, Gunnel, Reiland, Sven, Cosma, Antonio, Drexler, Ingo, Hinkula, Jorma, Wahren, Britta, Erfle, Volker
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1978202/ https://www.ncbi.nlm.nih.gov/pubmed/17623060 http://dx.doi.org/10.1186/1750-9378-2-14

Ejemplares similares

Immunization with HIV protease peptides linked to syngeneic erythrocytes
por: Boberg, Andreas, et al.
Publicado: (2007)

Receptor Binding by Cholera Toxin B-Subunit and Amino Acid Modification Improves Minimal Peptide Immunogenicity
por: Boberg, Andreas, et al.
Publicado: (2012)

Potent cellular and humoral immunity against HIV-1 elicited in mice by a DNA-prime/MVA-boost vaccine regimen intended for human use
por: Wahren, Britta, et al.
Publicado: (2006)

Skin Electroporation: Effects on Transgene Expression, DNA Persistence and Local Tissue Environment
por: Roos, Anna-Karin, et al.
Publicado: (2009)

Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation
por: Bråve, Andreas, et al.
Publicado: (2010)

Do circulating HIV vaccine plasmids contribute to immunogenicity in humans?
por: Wahren, B, et al.
Publicado: (2006)

Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice
por: Hinkula, Jorma, et al.
Publicado: (2019)

Immunotherapy with an HIV-DNA Vaccine in Children and Adults
por: Palma, Paolo, et al.
Publicado: (2014)

Endocine™, N3OA and N3OASq; Three Mucosal Adjuvants That Enhance the Immune Response to Nasal Influenza Vaccination
por: Falkeborn, Tina, et al.
Publicado: (2013)

Intracellular Targeting of CEA Results in Th1-Type Antibody Responses Following Intradermal Genetic Vaccination by a Needle-Free Jet Injection Device
por: Johansson, Susanne, et al.
Publicado: (2007)

P18-04. MVA-nef vaccination induces specific T-cell responses exerting functions associated with non-progressive disease in HIV-1 infected individuals
por: Kutscher, S, et al.
Publicado: (2009)

An affibody-adalimumab hybrid blocks combined IL-6 and TNF-triggered serum amyloid A secretion in vivo
por: Yu, Feifan, et al.
Publicado: (2014)

Cross-competition of CD8(+) T cells shapes the immunodominance hierarchy during boost vaccination
por: Kastenmuller, Wolfgang, et al.
Publicado: (2007)

A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines
por: Hallengärd, David, et al.
Publicado: (2012)

Induction of Noxa-Mediated Apoptosis by Modified Vaccinia Virus Ankara Depends on Viral Recognition by Cytosolic Helicases, Leading to IRF-3/IFN-β-Dependent Induction of Pro-Apoptotic Noxa
por: Eitz Ferrer, Pedro, et al.
Publicado: (2011)

Chemotactic activity of HIV-1 Nef for human monocytes
por: Lehmann, MH, et al.
Publicado: (2006)

Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev
por: Cardona, Maria E., et al.
Publicado: (2022)

HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial
por: Nilsson, Charlotta, et al.
Publicado: (2015)

A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro
por: Chang, Chien-Hsing, et al.
Publicado: (2012)

Foxp3+ Regulatory T-cells and IL-2: The Moirai of T-cell Fates?
por: Gasteiger, Georg, et al.
Publicado: (2012)

DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant
por: Nyström, Sanna, et al.
Publicado: (2013)

Nef-induced CCL2 Expression Contributes to HIV/SIV Brain Invasion and Neuronal Dysfunction
por: Lehmann, Michael H., et al.
Publicado: (2019)

Antigen-dependent competition shapes the local repertoire of tissue-resident memory CD8(+) T cells
por: Muschaweckh, Andreas, et al.
Publicado: (2016)

HIV-1 Nef: at the crossroads
por: Foster, John L, et al.
Publicado: (2008)

A Conserved GPG-Motif in the HIV-1 Nef Core Is Required for Principal Nef-Activities
por: Martínez-Bonet, Marta, et al.
Publicado: (2015)

Effects of naturally-arising HIV Nef mutations on cytotoxic T lymphocyte recognition and Nef's functionality in primary macrophages
por: Mwimanzi, Philip, et al.
Publicado: (2011)

HIV-1 Nef is released in extracellular vesicles derived from astrocytes: evidence for Nef-mediated neurotoxicity
por: Sami Saribas, A, et al.
Publicado: (2017)

Human Immunodeficiency Virus Type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains
por: Brügger, Britta, et al.
Publicado: (2007)

Self-association of the Lentivirus protein, Nef
por: Kwak, Youn Tae, et al.
Publicado: (2010)

The activity of Nef on HIV-1 infectivity
por: Basmaciogullari, Stéphane, et al.
Publicado: (2014)

60 Years of viral vaccines
por: Wahren, Britta
Publicado: (2022)

P19-29. Determining the optimal protocol for plasmid DNA vaccine delivery by intradermal in vivo electroporation
por: Hallengärd, D, et al.
Publicado: (2009)

Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
por: Malm, Magdalena, et al.
Publicado: (2013)

Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
por: Malm, Magdalena, et al.
Publicado: (2013)

HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV
por: Hinkula, J, et al.
Publicado: (2017)

α4-integrins control viral meningoencephalitis through differential recruitment of T helper cell subsets
por: Rothhammer, Veit, et al.
Publicado: (2014)

HIV-1 Nef targets calnexin: a novel mechanism behind Nef effects on host cell and viral proteins
por: Jennelle, Lucas, et al.
Publicado: (2013)

HIV-1 subtype C Nef-mediated SERINC5 down-regulation significantly contributes to overall Nef activity
por: Naicker, Delon, et al.
Publicado: (2023)

Nef-specific CD45RA+ CD8+ T cells secreting MIP-1β but not IFN-γ are associated with nonprogressive HIV-1 infection
por: Dembek, Claudia J, et al.
Publicado: (2010)

Uncovering metabolic pathways relevant to phenotypic traits of microbial genomes
por: Kastenmüller, Gabi, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3kbtq57cqn8pcsdp30cu6mh9pq